Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma.
about
RNA sequencing of pancreatic circulating tumour cells implicates WNT signalling in metastasisPersonalized Clinical Trials in Hepatocellular Carcinoma Based on Biomarker SelectionTumor Heterogeneity in Hepatocellular Carcinoma: Facing the ChallengesMolecular pathogenesis of hepatocellular carcinoma and impact of therapeutic advancesA concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010-2016Hepatocellular Carcinoma in Pakistan: National Trends and Global PerspectiveCancer Bioinformatic Methods to Infer Meaningful Data From Small-Size CohortsMolecular prognostic prediction in liver cirrhosisOverexpression of Leucine-Rich Repeat-Containing G Protein-Coupled Receptor 5 (LGR5) Represents a Typical Wnt/β-Catenin Pathway-Activated Hepatocellular CarcinomaBiological features and biomarkers in hepatocellular carcinomaMultimodal treatment of hepatocellular carcinoma on cirrhosis: an updateTargeting the mTOR pathway in hepatocellular carcinoma: current state and future trendsRole and regulation of β-catenin signaling during physiological liver growthMultidisciplinary perspective of hepatocellular carcinoma: A Pacific Northwest experience.Intrahepatic cholangiocarcinoma: pathogenesis and rationale for molecular therapiesMouse models of cancer: Sleeping Beauty transposons for insertional mutagenesis screens and reverse genetic studiesMolecular pathological epidemiology in diabetes mellitus and risk of hepatocellular carcinomaAberrant regulation of Wnt signaling in hepatocellular carcinomaInsights for hepatitis C virus related hepatocellular carcinoma genetic biomarkers: Early diagnosis and therapeutic interventionβ-Catenin Signaling and Roles in Liver Homeostasis, Injury, and TumorigenesisPrevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challengesMolecular classification and novel targets in hepatocellular carcinoma: recent advancementsCooperative antiproliferative effect of coordinated ectopic expression of DLC1 tumor suppressor protein and silencing of MYC oncogene expression in liver cancer cells: Therapeutic implicationsDysregulated serum response factor triggers formation of hepatocellular carcinomaRegulation of amphiregulin gene expression by β-catenin signaling in human hepatocellular carcinoma cells: a novel crosstalk between FGF19 and the EGFR systemScreening for hepatocellular carcinoma: patient selection and perspectivesLiver masses: a clinical, radiologic, and pathologic perspective.Hepatic disease biomarkers and liver transplantation: what is the potential utility of microRNAs?Development of biomarkers for screening hepatocellular carcinoma using global data mining and multiple reaction monitoring.SPARSE INTEGRATIVE CLUSTERING OF MULTIPLE OMICS DATA SETS.Pathway and network approaches for identification of cancer signature markers from omics data.Using Big Data to Discover Diagnostics and Therapeutics for Gastrointestinal and Liver Diseases.Integrated Multiple "-omics" Data Reveal Subtypes of Hepatocellular Carcinoma.Stem cells in hepatocarcinogenesis: evidence from genomic dataTRIB2 acts downstream of Wnt/TCF in liver cancer cells to regulate YAP and C/EBPα function.Systemic therapy for advanced hepatocellular carcinoma: an update.DNA methylation: potential biomarker in Hepatocellular Carcinoma.Hepatocellular Carcinomas Originate Predominantly from Hepatocytes and Benign Lesions from Hepatic Progenitor Cells.SERPINB3 is associated with TGF-β1 and cytoplasmic β-catenin expression in hepatocellular carcinomas with poor prognosis.Role of leukocyte cell-derived chemotaxin 2 as a biomarker in hepatocellular carcinoma.
P2860
Q24626854-8B5ECCBE-DFC3-4C76-8FED-78C2A8487FC0Q26738860-7A2E67C2-3DD0-4419-B1EE-EE110C35C0DAQ26744100-92B1312C-11DD-4DD7-A445-264577D09199Q26745338-5D5FB0C8-08CC-478E-AD0A-50A0982C883AQ26752478-C6A01BC0-655A-4536-A42A-6482E5DB351CQ26767217-D1899C93-849A-4928-8646-F5AB31644E3EQ26777117-997CCB79-3F3A-45B1-BC9B-207E92D0A2F5Q26784251-89610081-38AE-4DD4-A59A-E2A1AA909F36Q26797525-F48C4EAB-A5CB-4B8B-AAFF-AEBCB025A8BAQ26799462-28DCAC83-89D6-46F2-95B1-756D1BA97AE0Q26825172-025045F4-B6E7-44E8-BAAA-2D7866A8D63AQ26830194-B8ACBAC8-A785-4046-BBE8-F9BAE3313FC6Q26864289-EAF813AC-8DE1-4268-9CA0-C770E1C6AB12Q26998606-05F950C6-9A54-4C10-AF39-47F1FF09C962Q27002547-856206D1-3976-4FFE-859B-DCA48492136CQ27008537-E4E2438D-1B26-468F-98C6-A3243E7EC841Q28076106-15347F08-FDCF-4E76-9E26-96632584F0C0Q28079789-62A9D1B6-0A1B-47E2-9A5C-40B96E38E486Q28080281-1BFE2BE9-2918-4CBB-915A-9BDF8CE03082Q28087660-399CEC65-34C0-4604-B93B-3C16D01663B5Q28272678-F9ABF4BB-EBAB-4755-92FC-36C2B4034E12Q28383646-B51CF0EA-88B3-4221-B2CD-9236C8C8952EQ28384501-4B3CE2BD-55AA-4DC0-832D-D83D4C5DFE44Q28390147-AA66D586-45B1-4C7A-8C6E-24FCBAD2DDC8Q28484499-47CF9F70-CE99-48D4-A9D8-74FDB963012BQ30355713-F8847D1D-DAE8-4017-BCDA-DD30F9401278Q30403670-F845276F-4D58-47FE-90C6-03A8F17A18CFQ30456435-6667963B-C53F-4DD9-8124-E01BF2F944E7Q30635373-CD296C70-821B-471A-B9BD-869FB4B5ABE4Q30768936-732A4270-F499-41AE-B5CE-DEA7398BA9EAQ30882475-D0D85A9E-6796-46DD-8524-446F04492D59Q31138564-272B1CBF-4BFE-49EE-AD33-D43FE4C65A11Q31140554-C0D5AF65-6232-4755-A64E-D0A0C5D89CB9Q33533408-51453F7C-131E-4BCC-8E27-56B4A2DE1B8AQ33557334-86734844-3FFD-4119-94AA-52B67FDBE235Q33593213-5D3F9095-5B1D-4ACF-B9D1-BC2F405CF6D3Q33617129-1E54A4FC-A0FB-4A13-9648-EB3C7C86303AQ33617469-02E45449-32C9-400D-8537-1014CBD39085Q33683019-96EAE896-B5AE-4E66-8B07-B0B6D44E26BBQ33706930-6E7ED208-31D6-41B1-966F-5DA9B4C7733B
P2860
Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Integrative transcriptome anal ...... uman hepatocellular carcinoma.
@ast
Integrative transcriptome anal ...... uman hepatocellular carcinoma.
@en
type
label
Integrative transcriptome anal ...... uman hepatocellular carcinoma.
@ast
Integrative transcriptome anal ...... uman hepatocellular carcinoma.
@en
altLabel
Integrative transcriptome anal ...... human hepatocellular carcinoma
@en
prefLabel
Integrative transcriptome anal ...... uman hepatocellular carcinoma.
@ast
Integrative transcriptome anal ...... uman hepatocellular carcinoma.
@en
P2093
P2860
P1433
P1476
Integrative transcriptome anal ...... uman hepatocellular carcinoma.
@en
P2093
Augusto Villanueva
Derek Y Chiang
Goro Watanabe
Hiromitsu Kumada
Jean-Philippe Brunet
Jennifer A Chan
Kenji Ikeda
Masahiro Kobayashi
Masaji Hashimoto
Philippa Newell
P2860
P304
P356
10.1158/0008-5472.CAN-09-1089
P407
P577
2009-09-01T00:00:00Z